HIGHLIGHTS
- who: Wnt et al. from the Western University of Health Sciences, United States have published the research work: Crosstalk between Wnt/ u03b2 -catenin signaling pathway and DNA damage response in cancer: a new direction for overcoming therapy resistance, in the Journal: (JOURNAL)
SUMMARY
Numerous studies have demonstrated that DDR deficiency is closely associated with several diseases (Jackson and Bartek, 2009; Ciccia and Elledge, 2010; Lee and Paull, 2021; Stoof et_al, 2021; Ye et_al, 2021), among which cancer has become a focus of research. As the majority of anti-tumor therapies primarily target the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.